Department of Health and Human Services May 2, 2019 – Federal Register Recent Federal Regulation Documents
Results 1 - 17 of 17
Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients; Public Workshop; Request for Comments
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled ``Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients.'' The purpose of the public workshop is to discuss the scientific and clinical trial design considerations for development of antiviral products to treat adenoviral infection.
National Biodefense Science Board: In-Person Meeting
The HHS Office of the Secretary is hosting the National Biodefense Science Board (NBSB) at an In-Person Meeting in Washington, DC, on June 10-11, 2019. The purpose of the NBSB In-Person Meeting is to gather expert advice provided by NBSB and guidance to the Secretary on scientific, technical, and other matters of special interest to HHS regarding current and future chemical, biological, nuclear, and radiological agents, whether naturally occurring, accidental, or deliberate.
Medicare Program; Accrediting Organizations-Changes to Change of Ownership
This proposed rule would add requirements and a specified process to address changes of ownership as they relate to the sale, transfer, and/or purchase of assets of Accrediting Organizations (AOs) with the Centers for Medicare & Medicaid Services (CMS)-approved accreditation programs. This change is intended to provide CMS the ability to receive notice when an AO is contemplating undergoing or negotiating a change of ownership and the ability to review the AO's capability to perform its tasks after a change of ownership has occurred, in order to insure the ongoing effectiveness of the approved accreditation program(s) and to minimize risk to patient safety.
Preparation for International Cooperation on Cosmetics Regulation Thirteenth Annual Meeting; Public Meeting
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled ``International Cooperation on Cosmetics Regulation (ICCR)Preparation for ICCR-13 Meeting.'' The purpose of the public meeting is to invite public input on various topics pertaining to the regulation of cosmetics. We may use this input to help us prepare for the ICCR-13 meeting that will be held July 9 to 11, 2019, in Montreal, Canada.
Notice of a HRSA-Initiated Supplemental Award to Recipients in the Reaching Practicing Maternal and Child Health (MCH) Professionals in Underserved Areas Through Education and Training Program
HRSA announces the award of a supplement of $705,246 for the Reaching Practicing MCH Professionals in Underserved Areas through Education and Training Program (hereafter Program) recipients. The supplement will allow the current four recipients, during the period of June 1, 2019-May 31, 2020, to continue supporting the development and implementation of in-depth training tailored to the specific needs of MCH public health professionals practicing in underserved communities, including rural and frontier areas and Indian reservations.
Notice of a HRSA-Initiated Supplemental Award to the University of Nebraska Medical Center/Board of Regents of the University of Nebraska for the Partnership for Urban Maternal and Child Health (MCH) Leadership Community Cooperative Agreement
HRSA announces the award of a supplement for $700,000 to the University of Nebraska Medical Center/Board of Regents of the University of Nebraska for the Partnership for Urban MCH Leadership Community Cooperative Agreement. The supplement will allow the current recipient, during the period of May 1, 2019-April 30, 2020, to assess the outcomes and impact of its collective impact learning collaborative with urban health departments.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
